Skip to main content
logo
Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
441.00
+7.00 (1.61%)
May 6, 2026, 5:29 PM CET

Revenue by Segment

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Haematology
19.12B16.43B13.37B10.83B8.54B
Haematology Growth
16.36%22.88%23.44%26.89%-1.43%
Immunology
7.81B8.33B7.64B6.68B5.78B
Immunology Growth
-6.28%9.13%14.31%15.55%6.74%
Specialty Care
1.31B1.27B1.12B1.28B1.21B
Specialty Care Growth
3.55%13.23%-12.58%5.52%2.28%
Total
28.24B26.03B22.12B18.79B15.53B
Total Growth
8.49%17.65%17.74%21.00%1.76%

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
International
3.82B2.93B2.65B2.44B1.15B
International Growth
30.50%10.25%8.82%112.55%33.84%
Other
4.29B4.90B2.72B1.43B1.25B
Other Growth
-12.37%80.24%90.47%14.07%-3.84%
Europe (Excluding Sweden & Germany)
7.51B6.72B---
Europe (Excluding Sweden & Germany) Growth
11.85%----
Sweden
293.00M653.00M660.00M667.00M678.00M
Sweden Growth
-55.13%-1.06%-1.05%-1.62%-5.83%
North America (Excluding United States)
176.00M142.00M93.00M77.00M66.00M
North America (Excluding United States) Growth
23.94%52.69%20.78%16.67%37.50%
United States
9.14B8.37B8.15B7.36B6.05B
United States Growth
9.15%2.74%10.65%21.64%11.39%
Germany
3.01B2.32B--1.23B
Germany Growth
29.67%----14.67%
Europe (Excluding Sweden)
--7.85B6.82B-
Europe (Excluding Sweden) Growth
--15.17%--
France
----1.81B
France Growth
-----7.91%
Rest of Europe
----3.30B
Rest of Europe Growth
-----5.72%
Total
28.24B26.03B22.12B18.79B15.53B
Total Growth
8.50%17.65%17.74%21.00%1.76%
Source: S&P Global Market Intelligence.